DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 234 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $291,044 | +12.8% | 19,705 | -1.4% | 0.00% | 0.0% |
| Q2 2023 | $258,115 | +52.0% | 19,978 | +15.4% | 0.00% | 0.0% |
| Q1 2023 | $169,772 | -15.3% | 17,306 | -8.1% | 0.00% | 0.0% |
| Q4 2022 | $200,458 | +17.9% | 18,840 | +15.9% | 0.00% | 0.0% |
| Q3 2022 | $170,000 | -19.0% | 16,249 | -2.5% | 0.00% | 0.0% |
| Q2 2022 | $210,000 | -4.1% | 16,664 | -17.6% | 0.00% | – |
| Q1 2022 | $219,000 | -34.0% | 20,215 | -14.2% | 0.00% | -100.0% |
| Q4 2021 | $332,000 | +25.3% | 23,556 | +70.6% | 0.00% | 0.0% |
| Q3 2021 | $265,000 | -3.6% | 13,809 | -50.6% | 0.00% | 0.0% |
| Q2 2021 | $275,000 | -1.4% | 27,969 | -1.4% | 0.00% | 0.0% |
| Q1 2021 | $279,000 | +165.7% | 28,366 | +20.5% | 0.00% | – |
| Q4 2020 | $105,000 | +87.5% | 23,538 | +80.8% | 0.00% | – |
| Q3 2020 | $56,000 | -48.1% | 13,022 | +7.1% | 0.00% | -100.0% |
| Q2 2020 | $108,000 | +66.2% | 12,155 | +7.6% | 0.00% | – |
| Q4 2019 | $65,000 | – | 11,298 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |